Login / Signup

Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery.

Lorenz KollerEva SteinacherFelix HoferAndreas HammerNiema KazemGuenther LauferTatjana FleckBarbara SteinlechnerJohann WojtaBernhard RichterChristian HengstenbergPatrick SulzgruberAlexander Niessner
Published in: European journal of clinical investigation (2023)
The biomarker suPAR and NT-proBNP were strongly and independently associated with mortality in patients undergoing cardiac surgery. A simplified biomarker score comprising only 3 variables (age, suPAR and NT-proBNP) performed better than the established EuroScoreII with respect to intermediate and long-term outcome as well as hospitalization due to heart failure. As such, integration of established and upcoming biomarkers in clinical practice may provide improved decision support in cardiac surgery.
Keyphrases
  • cardiac surgery
  • patients undergoing
  • acute kidney injury
  • heart failure
  • clinical practice
  • cardiovascular events
  • left ventricular
  • atrial fibrillation
  • cardiovascular disease
  • type diabetes
  • coronary artery disease